This analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
Benchmark GlaxoSmithKline's performance against key rivals in the prescription pharmaceutical sector
Assess the threat posed by generic competition to GlaxoSmithKline's core prescription pharmaceutical business
Analyze the future strategic direction of GSK, namely an enhanced vaccine offering, geographic diversification and increased biologics presence
(0 items)
